The novel therapy of the medication represents a significant development in the management of type 2 diabetes. Different to existing drugs, tirzepatide targets multiple pathways – GLP-1 and GIP – resulting in https://tirzepatidepeptide741597.frewwebs.com/40700268/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment